JPS58162553A - 1,5-dimethyl-2-isopentylhexanol ester of higher fatty acid and cosmetic containing the same - Google Patents
1,5-dimethyl-2-isopentylhexanol ester of higher fatty acid and cosmetic containing the sameInfo
- Publication number
- JPS58162553A JPS58162553A JP4667582A JP4667582A JPS58162553A JP S58162553 A JPS58162553 A JP S58162553A JP 4667582 A JP4667582 A JP 4667582A JP 4667582 A JP4667582 A JP 4667582A JP S58162553 A JPS58162553 A JP S58162553A
- Authority
- JP
- Japan
- Prior art keywords
- dimethyl
- acid
- ester
- fatty acid
- isopentylhexanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 12
- 235000014113 dietary fatty acids Nutrition 0.000 title abstract description 11
- 239000000194 fatty acid Substances 0.000 title abstract description 11
- 229930195729 fatty acid Natural products 0.000 title abstract description 11
- 150000004665 fatty acids Chemical class 0.000 title abstract description 8
- -1 1,5-dimethyl-2-isopentylhexanol ester Chemical class 0.000 title description 18
- 150000001875 compounds Chemical class 0.000 claims abstract description 16
- 125000001931 aliphatic group Chemical group 0.000 claims abstract description 6
- 239000000203 mixture Substances 0.000 claims description 9
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- 229920006395 saturated elastomer Polymers 0.000 claims description 6
- 239000007788 liquid Substances 0.000 abstract description 24
- 150000002148 esters Chemical class 0.000 abstract description 17
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 abstract description 9
- 239000002253 acid Substances 0.000 abstract description 9
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract description 6
- 239000000839 emulsion Substances 0.000 abstract description 6
- 238000000034 method Methods 0.000 abstract description 6
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 abstract description 6
- 150000004820 halides Chemical class 0.000 abstract description 5
- 239000003814 drug Substances 0.000 abstract description 4
- 238000010438 heat treatment Methods 0.000 abstract description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 abstract description 3
- 239000002904 solvent Substances 0.000 abstract description 3
- 239000003795 chemical substances by application Substances 0.000 abstract description 2
- 230000007794 irritation Effects 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 150000004671 saturated fatty acids Chemical class 0.000 abstract description 2
- 238000003756 stirring Methods 0.000 abstract description 2
- 229940079593 drug Drugs 0.000 abstract 1
- 229940105132 myristate Drugs 0.000 abstract 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
- 238000004458 analytical method Methods 0.000 description 13
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 239000000243 solution Substances 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
- 239000000741 silica gel Substances 0.000 description 7
- 229910002027 silica gel Inorganic materials 0.000 description 7
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 6
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 6
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 5
- HIUZHBSLJXUFAA-UHFFFAOYSA-N 6-methyl-3-(3-methylbutyl)heptan-2-ol Chemical compound CC(C)CCC(C(C)O)CCC(C)C HIUZHBSLJXUFAA-UHFFFAOYSA-N 0.000 description 5
- 235000021360 Myristic acid Nutrition 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 239000003205 fragrance Substances 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 238000005160 1H NMR spectroscopy Methods 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 235000021355 Stearic acid Nutrition 0.000 description 4
- 239000003054 catalyst Substances 0.000 description 4
- 238000004440 column chromatography Methods 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 239000008117 stearic acid Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 235000021357 Behenic acid Nutrition 0.000 description 3
- 239000004166 Lanolin Substances 0.000 description 3
- 235000021314 Palmitic acid Nutrition 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 229940116226 behenic acid Drugs 0.000 description 3
- 238000011097 chromatography purification Methods 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000005886 esterification reaction Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 229940039717 lanolin Drugs 0.000 description 3
- 235000019388 lanolin Nutrition 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- 241000220317 Rosa Species 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000008406 cosmetic ingredient Substances 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000005809 transesterification reaction Methods 0.000 description 2
- ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- UNSAJINGUOTTRA-UHFFFAOYSA-N 3-(3-bromophenyl)prop-2-yn-1-ol Chemical compound OCC#CC1=CC=CC(Br)=C1 UNSAJINGUOTTRA-UHFFFAOYSA-N 0.000 description 1
- DHDXXPQDZIWOQY-UHFFFAOYSA-N 6-methyl-3-(3-methylbut-3-enyl)hept-6-en-2-one Chemical compound CC(=C)CCC(C(C)=O)CCC(C)=C DHDXXPQDZIWOQY-UHFFFAOYSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 101100327316 Schizosaccharomyces pombe (strain 972 / ATCC 24843) cdc18 gene Proteins 0.000 description 1
- SHEADHVPEQDCMI-UHFFFAOYSA-N [6-methyl-3-(3-methylbutyl)heptan-2-yl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC(C)C(CCC(C)C)CCC(C)C SHEADHVPEQDCMI-UHFFFAOYSA-N 0.000 description 1
- MNGFVPSJLKCLDU-UHFFFAOYSA-N [6-methyl-3-(3-methylbutyl)heptan-2-yl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(C)C(CCC(C)C)CCC(C)C MNGFVPSJLKCLDU-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000000262 chemical ionisation mass spectrometry Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 150000002194 fatty esters Chemical class 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000004313 glare Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000003209 petroleum derivative Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- HFRXJVQOXRXOPP-UHFFFAOYSA-N thionyl bromide Chemical compound BrS(Br)=O HFRXJVQOXRXOPP-UHFFFAOYSA-N 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
【発明の詳細な説明】
本発明は1,5−ジメチ・ルー2−イソペンチルヘキサ
ノールの高級脂肪酸エステルおよびそれを含有する化粧
料に関する。さらに評しくに、本発明は一般式(1)
(式中、Rは炭素原子数9〜21個の飽和tたは不飽和
の脂肪族炭化水素基を表わす。)で示される化合物およ
び鋏化合物を含有する化粧料に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to higher fatty acid esters of 1,5-dimethy-2-isopentylhexanol and cosmetics containing the same. More particularly, the present invention provides a compound represented by the general formula (1) (wherein R represents a saturated or unsaturated aliphatic hydrocarbon group having 9 to 21 carbon atoms) and a scissors compound. The present invention relates to cosmetics containing.
本発明者の一人とその共同発明者は、先に、テルペノイ
ド合成における重要な中間体である6−メチル−5−へ
ブテン−2−オンヲフレニルクロリドとア七トンから製
造する際の副生成物としであるいはまた6−メチル−5
−へブテン−2−オンとプノニルハライドとの縮合反応
によって得られる1、1−ジイソペンテニルアセトンを
水素添加することによシ、香料、化粧料基剤、溶剤など
として有用なT1式(II)
で示される1、5−ジメチル−2−イソペンチルヘキサ
ノールを提供した(特開昭56−135431号公報参
照)。One of the present inventors and his co-inventors previously discovered that 6-methyl-5-hebuten-2-one, an important intermediate in the synthesis of terpenoids, is a by-product produced from phrenyl chloride and a7tone. 6-methyl-5
By hydrogenating 1,1-diisopentenyl acetone obtained by the condensation reaction of -hebuten-2-one and pnonyl halide, the T1 formula ( II) 1,5-dimethyl-2-isopentylhexanol represented by the following was provided (see JP-A-56-135431).
本発明者らは、このたび、1,5−ジメチル−2−イソ
ペンチルヘキサノールの高級脂肪酸エステル類である一
般式(1)で示される新規化合物を合成し、該エステル
類が化粧料成分としての使用に好適な諸性質を備えるこ
とを見出し、本発明を完成するに至った。The present inventors have recently synthesized a new compound represented by the general formula (1), which is a higher fatty acid ester of 1,5-dimethyl-2-isopentylhexanol, and have discovered that the esters can be used as cosmetic ingredients. The present inventors have discovered that it has various properties suitable for use, and have completed the present invention.
一般式(しで示される本発明化合物の具体例として1,
5−ジメチル−2−イソペンチルヘキサノールのカプリ
ン酸、ウンデシル酸、ラウリン酸、ミリスチン酸、パル
ミチン酸、ステアリン酸、イソステアリン酸、ベヘン酸
などの飽和脂肪酸エステルおよび1.5−ジメチル−2
−イソペンチルヘキサノールトテシレン酸、クンデシレ
ン酸、パルミトレイン酸、オレイン酸、リルンII!、
リノール酸などの不飽邪脂肪酸エステルを挙げるこ
とができる。これらの″エステル類を化粧料用途に供す
る場合には、空気中での安定性の観点からは飽和脂肪酸
とのエステル類が好ましい。As a specific example of the compound of the present invention represented by the general formula (1),
Saturated fatty acid esters of 5-dimethyl-2-isopentylhexanol such as capric acid, undecylic acid, lauric acid, myristic acid, palmitic acid, stearic acid, isostearic acid, behenic acid and 1.5-dimethyl-2
-Isopentylhexanoltotecylenic acid, Kundecylenic acid, Palmitoleic acid, Oleic acid, Rirun II! ,
Unsaturated fatty acid esters such as linoleic acid can be mentioned. When these esters are used in cosmetics, esters with saturated fatty acids are preferred from the viewpoint of stability in the air.
本発明の化合物であ石1,5−ジメチルー2−イソペン
チルヘキサノールの高級脂肪酸エステル−Fil、 5
−ジメチル−2−イソペング・ルヘキサノールまたはそ
の反応性誘導体と上に述べたような炭素原子数10〜2
2個の脂肪酸またはその反応性誘導体(たとえば酸ハラ
イドあるいhエステルなと)とを反応させることによシ
容易に得られる。The compound of the present invention is higher fatty acid ester of 1,5-dimethyl-2-isopentylhexanol - Fil, 5
-dimethyl-2-isopengylhexanol or a reactive derivative thereof with 10 to 2 carbon atoms as mentioned above;
It is easily obtained by reacting two fatty acids or their reactive derivatives (eg, acid halides or h-esters).
エステル化反応またはエステル交換反応は自体公知の方
法および条件を用いて行うことができる。The esterification reaction or the transesterification reaction can be carried out using methods and conditions known per se.
反応性の高い誘導体の一つは脂肪酸の酸ハライドであり
、これを経る場合の好ましい具体例においては、先ず原
料脂肪酸1モルに対し、塩化チオニル、臭化チオニル、
三塩化リンなどのハロゲン化試薬を1〜2モル用い、両
者を0〜100℃で反応させて酸ハライドに導く。次い
でこの酸ノ・ライト1モルに対し1〜3モルの1.5−
ジメチル−2−イソペンチル−ヘキサノールと1〜3モ
ルのピリジン、キノリンなどの脱ノ・ロゲン化水素剤を
用い、これらをたとえばベンゼン、塩化メチレンなとの
溶媒中50〜100℃で加熱攪拌して反応させる。反応
混1合物から生成した・・ロゲン化水素アミン塙を除去
し、所望の水洗、乾燥、溶媒留去などの処理を行なった
のち蒸留精製して目的とするエステルを得る。One of the highly reactive derivatives is an acid halide of a fatty acid, and in a preferred example, first, thionyl chloride, thionyl bromide,
Using 1 to 2 moles of a halogenating reagent such as phosphorus trichloride, the two are reacted at 0 to 100°C to form an acid halide. Then, 1 to 3 mol of 1.5-
Using dimethyl-2-isopentyl-hexanol and 1 to 3 moles of a dehydrogenating agent such as pyridine or quinoline, these are heated and stirred at 50 to 100°C in a solvent such as benzene or methylene chloride to react. let The hydrogen halogenide amine layer produced from the reaction mixture is removed, and the desired esters are obtained by performing the desired treatments such as washing with water, drying, and distilling off the solvent, followed by purification by distillation.
また、本発明のエステル類は、反応性の高い誘導体を経
ることなく脂肪酸と1.5−ジメチル−2−丁ソペンチ
ルヘキサノールをそのまま反応させることによっても製
造することができる。この際、エステル化触媒は使用し
ても良いし、しなくてもよい。触媒を使用する場合Kt
i、脂肪酸と1.5−ジメチル−2−イソベンチルーヘ
キサノールとをパラトルエンスルホン酸、塩化亜鉛など
の触媒の存在下、ベンゼン、トルエンなどの不活性溶媒
中で加熱し、生成する水を共沸留去17ながら反応を行
う方法が好ましい。エステル化触媒を使用しない場合K
Fi、200〜230℃のような高温で減圧下に生成水
を留去しながら反応を行うことが好ましい。The esters of the present invention can also be produced by directly reacting fatty acids with 1,5-dimethyl-2-chopentylhexanol without using highly reactive derivatives. At this time, an esterification catalyst may or may not be used. Kt when using a catalyst
i. Heating fatty acids and 1,5-dimethyl-2-isobenthylhexanol in an inert solvent such as benzene or toluene in the presence of a catalyst such as para-toluenesulfonic acid or zinc chloride, and co-producing water. A method in which the reaction is carried out while distilling off by distillation (17) is preferred. K when no esterification catalyst is used
Fi, it is preferable to carry out the reaction at a high temperature such as 200 to 230° C. while distilling off the produced water under reduced pressure.
前記脂肪酸のメチルエステル、エチルエステルなどの低
級アルキルエステルと1.5−ジメチル−2−イソペン
チルヘキサノールとのエステル交換反応によっても容易
にかつ経済的Knr望のエステルを得ることができる。The desired ester can also be obtained easily and economically by a transesterification reaction between a lower alkyl ester such as methyl ester or ethyl ester of the fatty acid and 1,5-dimethyl-2-isopentylhexanol.
一般式(1)で示される本発明のエステル1llFi常
温で液体であり、その分子量から予想されるより低い曇
膚を有する。さらに1該エステル類を皮膚面に常用して
も刺激がなく、また咳エステル畑の経時的変化は小さい
。特に1.5−ジメチル−2−イソペンチルヘキサノー
ルの飽和脂肪着エステル類は空気中での安定性がすぐれ
ている。また、本発明グ、・エステル類を皮膚に塗布し
たときの感触試験では1)べたつきがない、2)のびが
よい、3)さっばりしている、4)吸収感、滲透感があ
る。5)なじみが良い、6)熱感がない、7)ぎらつき
がない、8)清らかさが良い、などの結果が得られた。The ester 1llFi of the present invention represented by general formula (1) is liquid at room temperature and has a lower cloudiness than expected from its molecular weight. Furthermore, regular use of the esters on the skin does not cause irritation, and changes in the cough ester field over time are small. In particular, saturated fatty esters of 1,5-dimethyl-2-isopentylhexanol have excellent stability in air. In addition, in the feel tests when the esters of the present invention were applied to the skin, they were found to be 1) non-sticky, 2) spreadable, 3) light, and 4) absorbent and permeable. Results included 5) good blendability, 6) no heat sensation, 7) no glare, and 8) good clarity.
本発明特
のエステル類%に飽和脂肪酸エステル類は・に皮膚に直
接使用する化粧料または外用剤(たとえば軟膏など)の
成分として有用でありフィーリングを向りさせる特徴を
有する。The esters and saturated fatty acid esters of the present invention are useful as components of cosmetics or external preparations (for example, ointments, etc.) that are used directly on the skin, and have characteristics that improve the feeling.
しかして1本発明により提供される化粧料は一般式(1
)で示される化合物を含有する(配合してなる)ことを
特徴とする。一般式(1)で示される化合物を化粧料に
配合する場合、水および他の油性物質を含む系に有効量
配合すれば良い。一般に、全組成物(化粧料)中、水1
〜99重景%好ましくは20〜90重I!に係、一般式
(1)で示される化合物0.01〜.25重fil好t
L<はo1〜1o重aSおよび他の油性物質0.1〜9
0TLt%好ましくFi1〜50重量%となるように配
合するのが適当である。上記の[−他の油性物質」とし
てはたとえば流動パラフィン、スクワラン、天然油脂、
高級脂肪酸、高級脂肪族アルコールおよびそれらのエス
テル類など、化粧料に配合しうろことが知られている油
性物質がいずれも使用可能であるn本発明の化粧料は上
記の他に化粧料に通常配合できるものはいずれも含むこ
とができ、このようなものとしてはたとえば保湿剤、増
粘剤、防腐剤、乳化剤、薬効成分、香料、乳化安定剤な
どがある・本発明化合物は上述のごとく特に化粧料成分
として有用であるが、その他にたとえば医薬品、嚢薬、
高分子材料などの油剤または乳剤に配合する油性成分と
しても有用である。Therefore, the cosmetic provided by the present invention has the general formula (1)
) It is characterized by containing (blending) the compound shown in the following. When the compound represented by the general formula (1) is incorporated into cosmetics, an effective amount may be incorporated into a system containing water and other oily substances. Generally, in the whole composition (cosmetic), 1 part of water
~99% weight, preferably 20-90% I! The compound represented by the general formula (1) is 0.01 to . 25 layer fil favorite
L< is o1~1o heavy aS and other oily substances 0.1~9
It is appropriate to mix it so that it is 0 TLt%, preferably Fi 1 to 50% by weight. Examples of the above [-other oily substances] include liquid paraffin, squalane, natural oils and fats,
Any of the oily substances known to be incorporated into cosmetics, such as higher fatty acids, higher aliphatic alcohols, and their esters, can be used. Anything that can be blended can be included, such as humectants, thickeners, preservatives, emulsifiers, medicinal ingredients, fragrances, emulsion stabilizers, etc. The compounds of the present invention are particularly suitable as described above. It is useful as a cosmetic ingredient, but it can also be used as a medicine, capsule medicine, etc.
It is also useful as an oily component added to oils or emulsions such as polymeric materials.
以下に本発明の化合物の製造例および本発明の化粧料の
配合例を実施例として示す。本発明はこれらの実施例に
限定される本のではない。Examples of manufacturing the compounds of the present invention and formulation examples of the cosmetics of the present invention are shown below. The invention is not limited to these examples.
実施例1
ミリスチン酸77、・f (0,337mol)をフラ
スコに入れ、これを100℃の油浴で加熱し、鱗かした
後、これに塩化チオニル31WI! (0,42mol
)を15分間で滴下した。千〇後4.5時間加熱還流
させ、50℃まで放冷した後、水流ポンプ減圧下で未反
応の塩化チオニルを除去し、塩化メチレン150111
:を加えて塩化ミリストイルの塩化メチレン溶液とした
。Example 1 Myristic acid 77,·f (0,337 mol) was placed in a flask, heated in a 100°C oil bath, scaled, and then added to thionyl chloride 31WI! (0.42 mol
) was added dropwise over 15 minutes. After heating under reflux for 4.5 hours and cooling to 50°C, unreacted thionyl chloride was removed under reduced pressure with a water jet pump, and methylene chloride 150111
: was added to prepare a methylene chloride solution of myristoyl chloride.
別のフラスコへ1.5−ジメチル−2−1/ヘンfルヘ
キ’r / k 67.56 f (0,337mo
l)、ピリジン41禦/(0,51mol)および4−
N、N−シ)fルアミノピリジン0.41 f (3,
4mmol)ノ塩化メチレン<340Il/)溶液を入
れ、これに先に調製した塩化ごリストイルの塩化メチレ
ン溶液を室温で滴Fした。滴ド終了彼、室温で13時間
がくはんし、さらに1.5時間加熱還流させた。放冷俵
、ヘキサン40011/を加え、沈殿を0別し、口板を
希塩酸、飽和NaHCOs水溶液で洗浄した。ヘキサン
層を無水Mg5Oaで乾燥し、ヘキサンを減圧下で菫去
すると茶色の液体133.Ofが得られた。To another flask add 1,5-dimethyl-2-1/hex'r/k 67.56 f (0,337 mo
l), pyridine 41/(0,51 mol) and 4-
N,N-cy)f ruaminopyridine 0.41 f (3,
4 mmol) methylene chloride<340 Il/) solution was added, and the previously prepared methylene chloride solution of ristoyl chloride was added dropwise at room temperature. After the addition was completed, the mixture was stirred at room temperature for 13 hours, and then heated under reflux for an additional 1.5 hours. A cooling bale and hexane 40011/ml were added, the precipitate was separated, and the mouth plate was washed with dilute hydrochloric acid and a saturated aqueous solution of NaHCOs. The hexane layer was dried over anhydrous Mg5Oa, and the hexane was removed under reduced pressure, resulting in a brown liquid 133. Of was obtained.
この液体を蒸留しく 230−250 ℃i 1 To
rr)、次いでシリカゲルを用いたカラムクロマトグラ
フィー[ヘキサン:イソプロピルエーテル−95:5色
透明な液体96.Ofを得た。この液体の分析結果を次
に示す。Distill this liquid at 230-250℃ i 1 To
rr) followed by column chromatography on silica gel [hexane:isopropyl ether-95:5 color clear liquid 96. I got Of. The analysis results of this liquid are shown below.
CI−MS (M生計算値410)
409、393
1H−NMR(δ、TMS基準、CDUs溶液〕4.9
2(m、IH)、 2.21(t、2H)。CI-MS (M raw calculated value 410) 409, 393 1H-NMR (δ, TMS standard, CDUs solution] 4.9
2 (m, IH), 2.21 (t, 2H).
1.801.04(m、 33H)、 0.8’2(m
、 18H)IR[KBr;yイルムコ
1735倒
上記の分析結果より、この液体がミリスチン酸1.5−
ジメチル−2−イソペンチルヘキシルであることを確認
したの収率tj69慢であっ六。1.801.04 (m, 33H), 0.8'2 (m
, 18H) IR [KBr;
The yield of dimethyl-2-isopentylhexyl was 69.
次に上記操作で得られたミリスチン酸1.5−ジメチル
−2−イソペンチルヘキシルの脱臭を行なった。蒸留装
置へこのエステル96.OFと水100t’6仕込み、
水流ポンプ減圧下、60−70″C,に加熱して水60
fを留去した。冷却後、残留物から有機層を分離し、飽
和NaHCOs水溶液で洗i後、無水MgSO4を用い
て乾燥し九(、MgSO4を0別し。Next, the 1,5-dimethyl-2-isopentylhexyl myristic acid obtained in the above procedure was deodorized. This ester96. OF and water 100t'6 preparation,
Heat the water to 60-70″C under vacuum with a water jet pump.
f was distilled off. After cooling, the organic layer was separated from the residue, washed with a saturated aqueous solution of NaHCOs, and dried using anhydrous MgSO4 to remove the MgSO4.
真空ポンプ減圧下で1時間室温で放置し、無色透明な液
体8301を得た。The mixture was left at room temperature for 1 hour under reduced pressure with a vacuum pump to obtain a colorless and transparent liquid 8301.
り上の操作により精製、脱臭したミリスチン酸1.5−
ジメチル−2−イソペンチルヘキシルの曇点を日本工業
規格石油製品曇り点試験方法に従って測定しまたとこる
一31℃であった。Myristic acid 1.5- purified and deodorized by the above procedure
The cloud point of dimethyl-2-isopentylhexyl was determined according to the Japanese Industrial Standards Petroleum Products Cloud Point Test Method and was -31°C.
−また、他の油脂とこのエステルとの相溶性を11℃で
試験した。その結果を次表に示す0表 1
! M elf 2
実施a1)1と同様な操作をミ+)ステン酸にかえτス
テア 1J > #95.99 (0,337mol
)を用いて行い、シリカゲルを用いたカラムクロマト精
製により無色透明な液体】022を得た。この液体の分
析結果を次に示す。- The compatibility of this ester with other fats and oils was also tested at 11°C. The results are shown in the table below. M elf 2 Execution a1) Perform the same operation as in 1 and change to m+) stenoic acid and τ stear 1J >#95.99 (0,337 mol
) and purified by column chromatography using silica gel to obtain a colorless and transparent liquid [022]. The analysis results of this liquid are shown below.
’H−NMR[δ、TM8基準、CDα3溶液]4.9
2 (m、 I H)? 2.20 (t−2H) T
1.801.05 (m、41H)、0.81 (”+
188 )l R(KBrフィルム〕
1735t?llI
ヒ記の分析結果より、この液体がステアリン酸1.5−
ジメチル−2−イソペンチルヘキシルであることを線間
した。収率は6511であった。'H-NMR [δ, TM8 standard, CDα3 solution] 4.9
2 (m, I H)? 2.20 (t-2H) T
1.801.05 (m, 41H), 0.81 (”+
188)l R (KBr film) 1735t?llI From the analysis results in
It was confirmed that it was dimethyl-2-isopentylhexyl. The yield was 6511.
実施例3
実施例1と同様な操作をミリスチン酸にかえてベヘン酸
115 f (0,337mol)を用いて行い、シリ
カゲルを用い九カラムクロiト精製により無色透明な液
体97.3fを得た。この液体の分析結果を次に示す□
’H−NMR[δ、TM8基準、CDα3溶液〕4.9
1(m、1)L)、 2.20(t、2)1)。Example 3 The same operation as in Example 1 was carried out using 115 f (0,337 mol) of behenic acid instead of myristic acid, and 97.3 f of a colorless and transparent liquid was obtained by chromatographic purification using nine columns using silica gel. The analysis results of this liquid are shown below □ 'H-NMR [δ, TM8 standard, CDα3 solution] 4.9
1(m, 1)L), 2.20(t, 2)1).
1.80−1.04(m、 49H)、、0.82(m
、 18)1)JR[KBrフィルム〕
17356R−1
F記の分析結果より、この液体がベヘンil 1.5−
ジメチル−2−イソペンチルヘキシルであることを―認
した。収率は55t4であった。1.80-1.04 (m, 49H), 0.82 (m
, 18) 1) JR [KBr film] 17356R-1 From the analysis results in F, this liquid is Behenil 1.5-
It was confirmed to be dimethyl-2-isopentylhexyl. The yield was 55t4.
実施例4
実施例1と同様な操作をミリスチン酸にかえてオレイン
酸95.2 F (0,337mol)を用いて行ない
、シリカゲルを用いたカラムクロマト精製により無色透
明な液体89.9Fを得意。この液体の分析結果を次に
示す。Example 4 The same operation as in Example 1 was carried out using 95.2 F (0,337 mol) of oleic acid instead of myristic acid, and a colorless and transparent liquid of 89.9 F was obtained by column chromatography purification using silica gel. The analysis results of this liquid are shown below.
’H,−NMR[:δ、TMS基準、 CDC18溶液
]5.30(m、2H)、 4.91(rn、IH)。'H, -NMR [: δ, TMS standard, CDC18 solution] 5.30 (m, 2H), 4.91 (rn, IH).
2.24(t、zH)、 1.97(m、nH)。2.24 (t, zH), 1.97 (m, nH).
1678−1.(15(m 、43 H) 、0−81
(m + 18 H)■RCKBrフィルム〕
1735m−1
E記の分析結果より、この液体がオレイン酸1.5−ジ
メチル−2−イソペンチルヘキシルであることを確Vし
た。収率は57嘔であった。1678-1. (15 (m, 43 H), 0-81
(m + 18 H) ■RCKBr film] 1735m-1 From the analysis results described in E, it was confirmed that this liquid was 1.5-dimethyl-2-isopentylhexyl oleate. The yield was 57 mm.
実施例5
実施例1におけるミリスチン酸Kかえてカブリ:1rl
t 58.1 f (0,337mol) を用イft
以外u’JNI例1と同様な操作を行い、シリカゲルを
用い九カラムクロマト精製により無色透明な液体710
fを得た。この液体の分析結果を次に示す。Example 5 Myristic acid K instead of fogging in Example 1: 1rl
If using t 58.1 f (0,337 mol)
Except for this, the same operation as u'JNI Example 1 was carried out, and a colorless and transparent liquid 710 was purified by nine column chromatography using silica gel.
I got f. The analysis results of this liquid are shown below.
’H−NMR[δ、TMS基準、CDα3溶液〕4.9
z(mt IH) 、 2.20 (t 、 2H)
。'H-NMR [δ, TMS standard, CDα3 solution] 4.9
z (mt IH), 2.20 (t, 2H)
.
1.80−1.05 (m 、25 H) t o、s
2 (mt 18 H)IR[KBrフィルム〕
1735(:Ill”
上町の分析結果より、この液体がカブ+7ン酸1.5−
ジメチル−2−イソペンチルヘキシルであることが確認
された。収率tli72%であった。1.80-1.05 (m, 25 H) to, s
2 (mt 18 H) IR [KBr film] 1735 (:Ill”) According to the analysis results of Uemachi, this liquid was
It was confirmed to be dimethyl-2-isopentylhexyl. The yield tli was 72%.
実施例6
実施例1におけるミリスチン酸にかえてラウリン酸67
.7 f (0,337mol)を用いた以外は実鳩例
1と同様な操作を行い、シリカゲルを用い九カラムクロ
マト精製により無色透明な液体76.32を得走。この
液体の分析結果を次に示す。Example 6 Lauric acid 67 instead of myristic acid in Example 1
.. The same operation as in Example 1 was carried out except that 7f (0,337 mol) was used, and a colorless and transparent liquid 76.32 was obtained by nine column chromatographic purification using silica gel. The analysis results of this liquid are shown below.
’H−NMRCJ、TMS基準、CDα3溶液〕4.9
2(m、IJ、2.19(t、2H)。'H-NMRCJ, TMS standard, CDα3 solution] 4.9
2(m, IJ, 2.19(t, 2H).
1.80−1.04(m、29H)、0.82(rn、
18H)IR[KBr;yイルムコ
1735tM’
h記の分析結果より、この液体がラウリン酸1.5−ジ
メチル−2−イソペンチルへ中シルであることが確聞さ
れた。収率は709Iであった。1.80-1.04 (m, 29H), 0.82 (rn,
18H) IR [KBr; yIlmuco 1735tM' From the analysis results in section h, it was confirmed that this liquid was 1,5-dimethyl-2-isopentyl laurate. The yield was 709I.
実施例7
実権例1におけるミリスチン酸にかえてパルミチン酸8
6.4 f (0,337mol)を用いた以外は実施
例1とlbJ様な操作を行い、シリカゲルを用いたカラ
ムクロマ・ト精製により無色透明な液体88.2 Fを
得た。この液体の分析結果を次に示す。Example 7 Palmitic acid 8 was used instead of myristic acid in Actual Example 1.
The same procedure as in Example 1 was carried out except that 6.4 F (0,337 mol) was used, and 88.2 F, a colorless and transparent liquid, was obtained by column chromatographic purification using silica gel. The analysis results of this liquid are shown below.
’)i−NMR[δ、TM8基準、CDα3溶液]4.
91(m、1)()、2.21(tt2H)11.80
−1.05(m、 37H) 、 0.83(m、 1
8H)IR[KBr)(ルム:]
1735m l
t−1kjの分析結果より、この液体がパルミチン酸1
.5−ジメチル−2−イソペンチルヘキシルであること
が硲駅された。収率は69チであった。') i-NMR [δ, TM8 standard, CDα3 solution] 4.
91 (m, 1) (), 2.21 (tt2H) 11.80
-1.05 (m, 37H), 0.83 (m, 1
8H) IR [KBr) (Rum:] 1735ml From the analysis results of t-1kj, this liquid is palmitic acid 1
.. It was determined to be 5-dimethyl-2-isopentylhexyl. The yield was 69 cm.
実施例8 (クリームへの配合例)(栄養クリーム)(
重を嘔)
ステアリン酸 3.00嘔セタ
ノール 1.5011り
IJセリールモノステアレー) 2.5
04(自己乳化型)
ステアリルアルコール 1,50悌脱水
ラノリン 2.001G流動パ
ラフイン 15.004トリエタ
ノールアミン 1.00憾プロ
ピレングリコール 60〇−精製
水 611O畳防腐剤(バ
ラオキシ安息香酸エステル) 0.10憾香料
0.30憾
り記成分のうち油脂成分を混合加a(75〜80℃)し
て溶解した。別に香料を除く水性成分を溶解加温して7
5〜80℃の水相とした。この水性を攪拌しつつ油相を
加えて乳化し、温[60〜65℃にて香料を加え、室温
まで冷却して製・とした。Example 8 (Example of formulation in cream) (Nutritional cream) (
Stearic acid 3.00 (Setanol 1.5011) 2.5
04 (Self-emulsifying type) Stearyl alcohol 1,50 dehydrated lanolin 2.001G liquid paraffin 15.004 Triethanolamine 1.00 Propylene glycol 60〇-Purified water 611O Tatami preservative (rose oxybenzoic acid ester) 0.10 Fragrance 0.30 Among the ingredients, the oil and fat components were mixed and dissolved at 75 to 80°C. Separately, dissolve and heat the aqueous ingredients excluding fragrance.7
It was set as the aqueous phase of 5-80 degreeC. The oil phase was added to the aqueous solution while stirring to emulsify it, and the fragrance was added at a temperature of 60 to 65° C., and the mixture was cooled to room temperature to prepare a product.
本製品は1.5−ジメチル−2−イソペンチルヘキサノ
ールエステルを配合しない以外は上記と同様の組成のク
リームに比較して皮膚に塗布したときの感触が顕著に良
好であった。This product had a significantly better feel when applied to the skin than a cream with the same composition as above except that 1,5-dimethyl-2-isopentylhexanol ester was not blended.
実施例9 (クリームへの配合)(栄養クリーム)(重
量9!i)
ステアリン酸 3.001セタ
ノール 150嘔グリセリ
ンモノステアレート(自己乳化fl) 2.5
01ステアリルアルコール 1.50憾
脱水ラノリン 20〇−流動パ
ラフィン 10.001!1スクワ
ラン 5.001トリエタノ
ールアミン 1.00嗟プロピレング
リコール 6.00係yI′fI製水
61.10チ防腐剤(パラ
オキシ安息香酸エステル) 0.10鴫香料
0304
1に、成分を実施例8と同様の方法によりへ合し製品と
した。本製品は皮膚に塗布したときのフィーリングが良
好であった。Example 9 (Formulation into cream) (Nutritional cream) (Weight 9!i) Stearic acid 3.001 Cetano 150 Glycerin monostearate (self-emulsifying fl) 2.5
01 Stearyl alcohol 1.50 Dehydrated lanolin 200-Liquid paraffin 10.001!1 Squalane 5.001 Triethanolamine 1.00 Propylene glycol 6.00 YI'fI water
61.10 Preservative (paraoxybenzoic acid ester) 0.10 Flavor 0304 1. The ingredients were combined in the same manner as in Example 8 to obtain a product. This product had a good feeling when applied to the skin.
実施例10(乳液への配合例)(栄養乳液)(重l1l
−11)
ステアリン酸 2.801セタ
ノール 170L4脱水ラノ
リン 0504ソルビタンモノ
ラウレー) 1.20%スクワラン
200鴫プロピレングリコール
250憾グリセリン
2.501トリエタノールアミン
+、(01嘔防腐剤(バラオキシ安息香酸エステ
ル) 0.10’11精製水
82.80鴫香料 020
憾
ヒ記成分を実施例8と同様の方法により配合し製品、L
: I、た。本製品は皮膚に塗布したときのフィリング
が良好であった。Example 10 (Example of blending into emulsion) (Nutritional emulsion) (weight 11 l
-11) Stearic acid 2.801 Cethanol 170L4 dehydrated lanolin 0504 Sorbitan monolaure) 1.20% Squalane
200% propylene glycol
250 Glycerin
2.501 triethanolamine
+, (01 Preservative (rose oxybenzoate ester) 0.10'11 Purified water
82.80 Shizuku fragrance 020
Regrettably, the ingredients were blended in the same manner as in Example 8 to produce a product, L.
: I, ta. This product had good filling when applied to the skin.
1組コリスチン酸1,5−ジメチル−2−イソペンチル
ヘキシルにかえてパルミチン酸1,5−ジメチル−2−
イソペンチルヘキシル、ステアリン酸1.5−ジメチル
−2−イソペンチルヘキシル、ラウリン酸1.5−ジメ
チル−2−イソペンチルヘキシルまたはベヘン酸1,5
−ジメチル−2−イソペンチルヘキシルを配合した乳液
も同様に皮膚に塗布し、たときの感触が良好であった。1 set 1,5-dimethyl-2-palmitate instead of 1,5-dimethyl-2-isopentylhexyl colistate
Isopentylhexyl, 1,5-dimethyl-2-isopentylhexyl stearate, 1,5-dimethyl-2-isopentylhexyl laurate or 1,5 behenic acid
An emulsion containing -dimethyl-2-isopentylhexyl was similarly applied to the skin and had a good feel when applied.
特許出願人株式会社り ラ し 代理人弁理士本多 竪Patent applicant: Rishi Co., Ltd. Representative Patent Attorney Tate Honda
Claims (1)
の脂肪族炭化水素基を表わす。)で示きれる化合物。 2一般式(1)におけるRが炭素原子数9〜21個の飽
和脂肪族炭化水素基□である特許請求の範囲第1項記載
の化合物。 3、一般式(1) %式%(3 (式中、Rは炭素原子数9〜21個の飽和オたは不飽和
の脂肪族炭化水素基を表わす。)で示される化合物を含
有することを特徴とする化粧料。 4、一般式(1) KおけるRが炭素原子数9〜21個
の飽和脂肪族炭化水素基である化合物を含有する特許請
求の範囲第3項記載の化粧料。[Scope of Claims] 1. A compound represented by the general formula (1) % formula % (wherein R represents a saturated or unsaturated aliphatic hydrocarbon group having 9 to 21 carbon atoms). 2. The compound according to claim 1, wherein R in the general formula (1) is a saturated aliphatic hydrocarbon group □ having 9 to 21 carbon atoms. 3. Contains a compound represented by the general formula (1) % formula % (3 (wherein R represents a saturated or unsaturated aliphatic hydrocarbon group having 9 to 21 carbon atoms) 4. The cosmetic composition according to claim 3, which contains a compound of general formula (1) in which R in K is a saturated aliphatic hydrocarbon group having 9 to 21 carbon atoms.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4667582A JPS58162553A (en) | 1982-03-23 | 1982-03-23 | 1,5-dimethyl-2-isopentylhexanol ester of higher fatty acid and cosmetic containing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4667582A JPS58162553A (en) | 1982-03-23 | 1982-03-23 | 1,5-dimethyl-2-isopentylhexanol ester of higher fatty acid and cosmetic containing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS58162553A true JPS58162553A (en) | 1983-09-27 |
JPH0158175B2 JPH0158175B2 (en) | 1989-12-11 |
Family
ID=12753942
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP4667582A Granted JPS58162553A (en) | 1982-03-23 | 1982-03-23 | 1,5-dimethyl-2-isopentylhexanol ester of higher fatty acid and cosmetic containing the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS58162553A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60146811A (en) * | 1983-12-30 | 1985-08-02 | Kuraray Co Ltd | Gel composition containing higher fatty acid ester with 1,5-dimethyl-2-isopentylhexanol and cosmetic and ointment containing the same |
US4639369A (en) * | 1986-03-03 | 1987-01-27 | Revlon, Inc. | Higher acyl lower alkyl hydroxystearates useful in cosmetics |
JP2008127340A (en) * | 2006-11-22 | 2008-06-05 | Nikko Chemical Co Ltd | Fatty acid ester and cosmetic |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56135431A (en) * | 1980-03-27 | 1981-10-22 | Kuraray Co Ltd | Substituted isopropyl alcohol |
JPS576790A (en) * | 1980-06-13 | 1982-01-13 | Canon Inc | Recording liquid and recording method |
-
1982
- 1982-03-23 JP JP4667582A patent/JPS58162553A/en active Granted
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56135431A (en) * | 1980-03-27 | 1981-10-22 | Kuraray Co Ltd | Substituted isopropyl alcohol |
JPS576790A (en) * | 1980-06-13 | 1982-01-13 | Canon Inc | Recording liquid and recording method |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60146811A (en) * | 1983-12-30 | 1985-08-02 | Kuraray Co Ltd | Gel composition containing higher fatty acid ester with 1,5-dimethyl-2-isopentylhexanol and cosmetic and ointment containing the same |
US4639369A (en) * | 1986-03-03 | 1987-01-27 | Revlon, Inc. | Higher acyl lower alkyl hydroxystearates useful in cosmetics |
JP2008127340A (en) * | 2006-11-22 | 2008-06-05 | Nikko Chemical Co Ltd | Fatty acid ester and cosmetic |
Also Published As
Publication number | Publication date |
---|---|
JPH0158175B2 (en) | 1989-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69429513T2 (en) | POLYPHENOL DERIVATIVE COMPOSITIONS AND THEIR PRODUCTION | |
JPS5923320B2 (en) | Branched fatty acid cholesteryl ester | |
JPH0517399A (en) | Ester derivative and cosmetics containing the same derivative | |
US4078147A (en) | Hydroxy acid esters of higher alcohols | |
JPS58162553A (en) | 1,5-dimethyl-2-isopentylhexanol ester of higher fatty acid and cosmetic containing the same | |
JPS5929055B2 (en) | Neopentyl alcohol ester and cosmetics containing it | |
DE69006647T2 (en) | 5,6,7,8-tetrahydro-1-naphthalenol derivatives, process for their preparation and their use as antioxidants in cosmetic and pharmaceutical compositions. | |
JPS6241202B2 (en) | ||
JPS63216812A (en) | Skin drug for external use | |
JPH08291045A (en) | Stabilizer consisting of fluorohydrocarbon compound in emulsion | |
JPS591407A (en) | Cosmetic containing branched fatty acid cholesteryl ester | |
JP2636896B2 (en) | Phospholipid emulsifier | |
JPH0763613B2 (en) | Water-in-oil emulsion composition | |
JPS62181236A (en) | Novel ester and cosmetic containing said ester | |
JPH0696490B2 (en) | External skin composition | |
JPS6126965B2 (en) | ||
JPS5824512A (en) | Sunscreen composition | |
JP2512401B2 (en) | Methyl-4,6-0- (7-hydroxy-3,7-dimethyl) octylidene-D-glycoside | |
JPS638932B2 (en) | ||
JP2542009B2 (en) | Liquid oil | |
JPH05320152A (en) | Glabridin derivative | |
JPS597712B2 (en) | Method for producing γ-lactone derivative | |
US3857898A (en) | 1-(3{40 -hexenyl)-1-cycloalkanols | |
JP2840145B2 (en) | p-menthan-2-methyl-3,8-diol and p-menthan-2-methylene-3,8-diol | |
DE68908020T2 (en) | Anti-inflammatory agent for the treatment of pathological prostate enlargement, a process for its preparation and pharmaceutical compositions containing it. |